Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3702 Npa101.3
Second-Generation RET/VEGFR2 Inhibitor
More description
DCC3701 Np-005497
Natural inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thaliana
More description
DCC3700 Novolactone
Natural inhibitor of the allosteric regulation of Hsp70
More description
DCC3699 Nov-lrrk2-11
Novel potent LRRK2 inhibitor
More description
DCC3698 Notum-in-24
Novel potent notum inhibitor (OPTS IC50 3.6nM; TCF-LEF EC50 220nM), showing good plasma exposure and reasonable CNS penetration
More description
DCC3697 Notum-in-23dd
Novel potent inhibitor of notum carboxylesterase activity
More description
DCC3696 Noscapine
Natueal sigma receptor agonist, attenuating cytokine release associated with SARS-CoV-2, also being used as anti-malarial, anti-stroke and cough-suppressant
More description
DCC3695 No-rosa5
Controllable nitric oxide (NO) donor, releasing NO triggered by photoinduced electron transfer (PeT)
More description
DCC3694 Noricumazole A
Secondary metabolite from the myxobacterium Sorangium cellulosum, acting as a potent HCV inhibitor, Ebola virus (EBOV) entry inhibitor, and a potassium channel inhibitor
More description
DCC3693 Norgestomet
Steroidal progestin used in veterinary medicine to control estrus and ovulation in cattle
More description
DCC3692 Nor-fauc-365
FAUC-365 analog
More description
DCC3691 Nord-1
Novel red-light-controllable nitric oxide (NO) releaser
More description
DCC3690 Nonoxynol-9
Novel human epidermal growth factor receptor-2 (HER2) inhibitor; Spermatocide
More description
DCC3689 Nomegestrol Acetate
Neutral, nonandrogenic, progesterone-like profile progestin
More description
DCC3688 Nomegestrol
Steroidal progestin
More description
DCC3687 N-oleoylethanolamine
PPARalpha agonist and EC 3.5.1.23 (ceramidase) inhibitor
More description
DCC3686 Nociceptin
Neuropeptide, acting as a endogenous ligand for the nociceptin receptor (NOP, ORL-1)
More description
DCC3685 nocazine E
Marine natural nocazine family member; Standard used in nocazine biosynthetic parthway studies
More description
DCC3684 nocazine C
Nocazine family member
More description
DCC3683 Nocathiacin I
Natural Inhibitor of an Oncogenic RNA, targeting RNA folds in the nuclease processing site in the oncogenic, noncoding microRNA-18a, selectively inhibiting nuclease processing in vitro and in prostate cancer cells and triggering apoptosis
More description
DCC3682 Nocardicin G
The universal precursor of the nocardicins
More description
DCC3681 Nocardicin A
Moderate antibiotic agent against a broad spectrum of gram-negative bacteria
More description
DCC3680 nnrti F2
Novel non-nucleoside reverse transcriptase inhibitor (NNRTI)
More description
DCC3679 Nnmt Inhibitor Ns1
Novel potent alkynyl bisubstrate inhibitor of nicotinamide N-methyltransferase (NNMT)
More description
DCC3678 Nn-dnj
Iminosugar, binding to the active site of lysosomal beta-glucosidase and stabilizing the proper folding for the catalytic form, acting as a chemical chaperone that facilitate transport and maturation of acid beta-Glu
More description
DCC3677 Nnc-38-1049
Novel selective histamine H3 antagonist
More description
DCC3676 N-n-butyl Haloperidol Iodide
Novel inhibitor of autophagy, protecting cardiomyocytes against hypoxia/reoxygenation injury
More description
DCC3675 Nn9056
Novel Potent and Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor (CCK-1R) Agonist
More description
DCC3674 Nms-p953
Novel JAK2 inhibitor, displaying significant tumor growth inhibition in SET-​2 xenograft tumor model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile
More description
DCC3673 Nms-p715 Analog
Novel selective and orally bioavailable MPS1 inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X